Market Access

Move therapies from approval to impact with a 360° perspective

With every new medical therapy, gaining regulatory approval is just the beginning. The ultimate goal is real-world adoption — where an affordable, reimbursable therapy reaches the patients who need it. And that requires navigating a dynamic, evolving discipline critical to business success.

The HawkPartners Market Access team works with pharmaceutical leaders across the globe to translate payer and health system expectations into clear, actionable insights — leading directly to client strategies that align with market realities.

A Comprehensive View

HawkPartners approaches Market Access with a 360° view of healthcare decision making to uncover the drivers and barriers that shape coverage, formulary placement, affordability and real-world adoption. Our work considers payer, provider, health system and specialty pharmacy to understand how coverage decisions are made, and how clinical evidence, value analysis and market dynamics influence uptake across the healthcare landscape.

Our experienced Partners bring three key Market Access advantages to your table:

Ecosystem Expertise

We understand how decisions are made, how influence flows across stakeholders, and how access shapes HCP and patient decision-making at every stage.

Early Alignment

With Market Access guiding our engagements from day one, we ensure strategy and execution align with real-world access and affordability dynamics.

Proven Impact

Year after year, life sciences clients trust us to develop evidence, messaging and engagement strategies that enable access and drive brand success.

Your Needs: Our Mission

We support clients in solving their Market Access challenges across every phase of the product lifecycle — from the payers and health systems shaping coverage to the providers and pharmacies driving real-world access.

Stakeholders

Stakeholders include Health Systems / Integrated Delivery Networks, Providers, Pharmacy Benefit Managers, Specialty Pharmacies, Health Plans, and Employer Sponsors.

Project Types

Growth Potential

(Early Asset / Indication Shaping)

Disease attitudes and awareness
Therapeutic attitudes and awareness
Payer landscape assessment
Early value hypothesis exploration

Launch Strategy Development

Disease attitudes and awareness
Therapeutic attitudes and awareness
P&T decision mapping
Value proposition testing
Reimbursement attitudes and guidelines
Payment model assessment
Pricing and contracting readiness
Non-prescribing stakeholder segmentation

Launch Readiness

Therapeutic attitudes and awareness
P&T decision mapping
Value proposition testing
Message and concept testing
Reimbursement attitudes and guidelines
Payment model assessment
Go-to-market sales and marketing story development
Pricing and contracting readiness
Account team objection handler development
Distribution strategy planning

Post-Launch Growth

P&T decision-making reassessment
Message and concept optimization
Access and reimbursement support satisfaction
Customer experience mapping
Competitive response tracking
Contracting effectiveness testing

New Market Event/New Formulation

P&T decision mapping/scenario-based assessment
Message and concept testing (reframing value)
Reimbursement attitudes and guidelines
Customer experience mapping
Payment model assessment
Pricing and contracting strategy re-evaluation

Proactive Access Strategies

Access dynamics ultimately determine whether a therapy reaches patients — influencing everything from uptake and affordability to overall brand performance. In today’s environment, success depends on anticipating how payers, health systems and other decision-makers will respond long before a product enters the market.

Our Market Access practice helps clients stay ahead of these forces by:

Anticipating payer decision-making criteria
Navigating evolving competitive and regulatory pressures
Preparing for market events before they happen

By integrating insights gained across the 360° ecosystem, we develop strategies grounded in market realities, aligned across stakeholders and resilient to change.

Embedding Access Into Strategy

Market Access is a strategic lens that informs how HawkPartners teams think about growth, positioning and performance across every healthcare engagement — even when projects are not explicitly access-focused.

In our experience, brand, insights, commercial and portfolio teams can all benefit from a clear understanding of payer expectations, evidence requirements, affordability pressures and system-level behaviors that ultimately shape adoption. Our experience across a range of stakeholders and therapeutic areas enables us to: